SGCB and heart failure: Additionally, in a pressure-induced model of heart failure, sGC stimulators mitigated cardiac fibrosis by inhibiting the expression and activity of angiotensin-converting enzyme (ACE), thereby reducing angiotensin II production in the myocardium [22].